Gastroparesis Treatment Market, By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Others), By Disease Indication (Diabetes Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis), By Type (Over-the-Counter Drugs and Prescription Drugs), By Route of Administration (Oral, Injectables, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025

Code : CMI5123

Pages :237

Formats :

Excel and PDF

Industry : Pharmaceutical

Gastroparesis Treatment Market Size and Trends

Global gastroparesis treatment market is estimated to be valued at USD 8.33 Bn in 2025 and is expected to reach USD 11.58 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032. The market growth is driven by increasing prevalence of gastroparesis globally.

Gastroparesis Treatment Market Key Factors

To learn more about this report, Request sample copy

Market Driver - Rising awareness regarding gastroparesis treatment

Gastroparesis, commonly known as delayed gastric emptying, is a condition where the stomach takes too long to empty its contents. For many years, it went undiagnosed or was confused with other gastrointestinal disorders. However, over the past decade, recognition of gastroparesis as a distinct clinical entity has improved tremendously due to initiatives by patient advocacy groups who have helped spread awareness about the condition and its treatments. Support communities formed by patients on social media platforms have provided invaluable peer support for those suffering from gastroparesis. Through open discussions, reputed doctors and specialists have been able to address common myths and misconceptions about the disease. Their efforts have led to a better understanding that gastroparesis is not just a stomach problem but can severely impair quality of life, if left untreated. Individuals are now more knowledgeable about seeking timely medical help rather than suffering silently. Awareness drives conducted by advocacy organizations in collaboration with medical professionals have effectively reached both urban and rural populations. Educational campaigns through various online and offline mediums highlight the signs and symptoms of gastroparesis along with stressing the importance of early diagnosis. This allows patients to recognize warning signs in the early stages itself and get appropriate treatment before complications arise. Healthcare providers are also alert to include gastroparesis in their differential diagnosis for gastrointestinal disorders.